Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Blood Advances
|
August 8, 2022
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
Jennifer M Logue, Lauren C Peres, Hamza Hashmi, et al.
Blood Advances
|
August 28, 2025
Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell Leukemia
Gliceida M Galarza Fortuna, Lauren C Peres, Elena Nazarenko, et al.
Transplantation and Cellular Therapy
|
April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
Roni Shouval, Christopher Strouse, Soyoung Kim, et al.
Blood
|
April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
Kai Rejeski, Jaime Sanz, Teng Fei, et al.
The New England Journal of Medicine
|
December 9, 2025
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
Luciano J Costa, Nizar J Bahlis, Aurore Perrot, et al.
Blood Neoplasia
|
March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas
Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood Advances
|
August 14, 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2025
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
Doris K Hansen, Lauren C Peres, Danai Dima, et al.
The New England Journal of Medicine
|
June 6, 2022
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Paul G Richardson, Susanna J Jacobus, Edie A Weller, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Blood Advances
|
August 8, 2022
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
Jennifer M Logue, Lauren C Peres, Hamza Hashmi, et al.
Blood Advances
|
August 28, 2025
Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell Leukemia
Gliceida M Galarza Fortuna, Lauren C Peres, Elena Nazarenko, et al.
Transplantation and Cellular Therapy
|
April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
Roni Shouval, Christopher Strouse, Soyoung Kim, et al.
Blood
|
April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
Kai Rejeski, Jaime Sanz, Teng Fei, et al.
The New England Journal of Medicine
|
December 9, 2025
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
Luciano J Costa, Nizar J Bahlis, Aurore Perrot, et al.
Blood Neoplasia
|
March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas
Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood Advances
|
August 14, 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2025
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
Doris K Hansen, Lauren C Peres, Danai Dima, et al.
The New England Journal of Medicine
|
June 6, 2022
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Paul G Richardson, Susanna J Jacobus, Edie A Weller, et al.
Page
of 10